• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊收缩素与FLFQPQRF-NH2在大鼠脊髓中与μ和δ阿片类镇痛的差异相互作用。

Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord.

作者信息

Magnuson D S, Sullivan A F, Simonnet G, Roques B P, Dickenson A H

机构信息

Department of Pharmacology, University College, London.

出版信息

Neuropeptides. 1990 Aug;16(4):213-8. doi: 10.1016/0143-4179(90)90065-7.

DOI:10.1016/0143-4179(90)90065-7
PMID:2177165
Abstract

An in vivo preparation of the rat spinal cord was used to investigate the electrophysiological actions of two non-opioid peptides, cholecystokinin (CCK8) and FLFQPQRF-NH2 (FMRFamide-like peptide) applied intrathecally. These compounds were examined alone and as a pretreatment before DAGO, a mu opioid agonist, and DSTBULET, a delta opioid agonist, both which selectively reduce C-fibre evoked dorsal horn neurone activity elicited by transcutaneous electrical stimulation. Given alone, CCK8 (1 microgram) elicited a modest enhancement of C-fibre induced activity which returned to control levels after 20 min, while FLFQPQRF-NH2 (10 micrograms) had no significant effect on C-fibre evoked firing. As a pretreatment, however, both peptides selectively prevented the inhibition of C-fibre evoked activity normally resulting from intrathecal DAGO, while having no effect on that resulting from DSTBULET. Further, CCK8 enhanced the facilitation of C-fibre evoked firing normally observed with low doses of DAGO. These data indicate that the anti-opioid roles suggested for CCK8 and FLFQPQRF-NH2 may be specific for neural elements utilizing the mu opioid receptor.

摘要

采用大鼠脊髓的体内制备方法,研究鞘内注射两种非阿片肽——胆囊收缩素(CCK8)和FLFQPQRF-NH2(FMRF酰胺样肽)的电生理作用。单独检测这些化合物,并在给予μ阿片受体激动剂DAGO和δ阿片受体激动剂DSTBULET之前进行预处理,这两种激动剂均能选择性降低经皮电刺激诱发的C纤维引起的背角神经元活动。单独给予时,CCK8(1微克)引起C纤维诱导活动适度增强,20分钟后恢复至对照水平,而FLFQPQRF-NH2(10微克)对C纤维诱发的放电无显著影响。然而,作为预处理,两种肽均能选择性地阻止鞘内注射DAGO通常引起的C纤维诱发活动的抑制,而对DSTBULET引起的抑制无影响。此外,CCK8增强了低剂量DAGO通常观察到的C纤维诱发放电的易化作用。这些数据表明,CCK8和FLFQPQRF-NH2所提示的抗阿片作用可能对利用μ阿片受体的神经元元件具有特异性。

相似文献

1
Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord.胆囊收缩素与FLFQPQRF-NH2在大鼠脊髓中与μ和δ阿片类镇痛的差异相互作用。
Neuropeptides. 1990 Aug;16(4):213-8. doi: 10.1016/0143-4179(90)90065-7.
2
Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
Brain Res. 1991 Jul 19;554(1-2):299-303. doi: 10.1016/0006-8993(91)90204-9.
3
Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
Neurosci Lett. 1992 Jan 6;134(2):238-42. doi: 10.1016/0304-3940(92)90525-c.
4
Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.胆囊收缩素及其拮抗剂对大鼠背角α2-肾上腺素能和阿片类脊髓镇痛的差异调节:一项电生理学研究
Brain Res. 1994 Oct 31;662(1-2):141-7. doi: 10.1016/0006-8993(94)90806-0.
5
Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.鞘内注射δ和μ阿片受体激动剂对福尔马林诱发的伤害感受及大鼠脊髓中Fos样免疫反应表达的不同影响。
J Pharmacol Exp Ther. 1998 Jan;284(1):378-87.
6
Opioid receptor subtypes in the rat spinal cord: electrophysiological studies with mu- and delta-opioid receptor agonists in the control of nociception.
Brain Res. 1987 Jun 9;413(1):36-44. doi: 10.1016/0006-8993(87)90151-x.
7
Electrophysiological studies on the spinal effects of dermorphin, an endogenous mu-opioid agonist.对内源性μ阿片受体激动剂皮啡肽的脊髓效应的电生理研究。
Brain Res. 1988 Sep 27;461(1):182-5. doi: 10.1016/0006-8993(88)90738-x.
8
Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.链脲佐菌素诱导的糖尿病选择性地改变了μ阿片受体激动剂产生的镇痛效力,但不影响δ和κ阿片受体激动剂产生的镇痛效力。
Brain Res. 1992 Feb 7;571(2):199-203. doi: 10.1016/0006-8993(92)90655-s.
9
Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.阿片受体(μ、δ1、δ2)在调节大鼠延髓(三叉神经尾侧核)浅部和深部背角伤害性神经元反应中的作用。
Brain Res. 1996 Nov 11;739(1-2):235-43. doi: 10.1016/s0006-8993(96)00828-1.
10
Evidence that endogenous enkephalins produce delta-opiate receptor mediated neuronal inhibitions in rat dorsal horn.内源性脑啡肽在大鼠背角产生δ-阿片受体介导的神经元抑制作用的证据。
Neurosci Lett. 1986 Dec 12;72(2):179-82. doi: 10.1016/0304-3940(86)90076-5.

引用本文的文献

1
Coordinated activity of a central pathway drives associative opioid analgesic tolerance.中枢通路的协调活动驱动阿片类药物的关联镇痛耐受。
Sci Adv. 2023 Feb 10;9(6):eabo5627. doi: 10.1126/sciadv.abo5627. Epub 2023 Feb 8.
2
Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.阿片系统与抗阿片系统的串扰:概述及其可能的治疗意义。
Biomolecules. 2020 Sep 28;10(10):1376. doi: 10.3390/biom10101376.
3
Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.
新型酰肼连接双功能肽作为δ/μ阿片受体激动剂和CCK-1/CCK-2受体拮抗剂的设计与合成
J Med Chem. 2006 Mar 9;49(5):1773-80. doi: 10.1021/jm050851n.
4
A locus and mechanism of action for associative morphine tolerance.联合吗啡耐受性的一个基因座及作用机制。
Nat Neurosci. 2000 Jan;3(1):47-53. doi: 10.1038/71120.
5
Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.脑啡肽分解代谢抑制剂与CCK - B拮抗剂的联合应用:在疼痛管理和阿片类药物成瘾治疗中的潜在用途。
Neurochem Res. 1996 Nov;21(11):1397-410. doi: 10.1007/BF02532381.
6
Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.阿片受体在神经肽FF类似物脊髓抗伤害感受作用中的角色。
Br J Pharmacol. 1996 Feb;117(3):493-501. doi: 10.1111/j.1476-5381.1996.tb15217.x.
7
Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.胆囊收缩素作为角叉菜胶炎症后脊髓吗啡效力增强的一个因素。
Br J Pharmacol. 1993 Apr;108(4):967-73. doi: 10.1111/j.1476-5381.1993.tb13493.x.
8
Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.胆囊收缩素在脊髓上水平对阿片类药物镇痛作用的调节:胆囊收缩素与脑啡肽系统在疼痛控制中的调节机制证据
Br J Pharmacol. 1993 Aug;109(4):1064-70. doi: 10.1111/j.1476-5381.1993.tb13730.x.
9
Dexamethasone-induced selective inhibition of the central mu opioid receptor: functional in vivo and in vitro evidence in rodents.地塞米松诱导的对中枢μ阿片受体的选择性抑制:啮齿动物体内和体外的功能证据
Br J Pharmacol. 1994 Dec;113(4):1416-22. doi: 10.1111/j.1476-5381.1994.tb17155.x.
10
Spinal opioid systems in inflammation.炎症中的脊髓阿片系统。
Inflamm Res. 1995 Jun;44(6):231-41. doi: 10.1007/BF01782974.